Recently, Novozymes applied Riffyn Nexus as an integral part of their innovative digital backbone to reduce both product development time and R&D personnel effort by 50% in their advanced biofuels yeast product portfolio. It helped bring to market four breakthrough strains in 18 months with Nexus as a central element of the success.
Enhance real-time collaboration on experiment design and data analytics across its sites
Increase in strain build and screening throughput by an order of magnitude
Slash product development time by 50% using half the personnel